1. Home
  2. ENSC vs CASK Comparison

ENSC vs CASK Comparison

Compare ENSC & CASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • CASK
  • Stock Information
  • Founded
  • ENSC 2003
  • CASK 2011
  • Country
  • ENSC United States
  • CASK United States
  • Employees
  • ENSC N/A
  • CASK N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • CASK
  • Sector
  • ENSC Health Care
  • CASK
  • Exchange
  • ENSC Nasdaq
  • CASK NYSE
  • Market Cap
  • ENSC 7.9M
  • CASK 6.5M
  • IPO Year
  • ENSC N/A
  • CASK 2024
  • Fundamental
  • Price
  • ENSC $5.40
  • CASK $1.16
  • Analyst Decision
  • ENSC
  • CASK
  • Analyst Count
  • ENSC 0
  • CASK 0
  • Target Price
  • ENSC N/A
  • CASK N/A
  • AVG Volume (30 Days)
  • ENSC 26.4K
  • CASK 132.1K
  • Earning Date
  • ENSC 03-14-2025
  • CASK 03-04-2025
  • Dividend Yield
  • ENSC N/A
  • CASK N/A
  • EPS Growth
  • ENSC N/A
  • CASK N/A
  • EPS
  • ENSC N/A
  • CASK N/A
  • Revenue
  • ENSC $4,421,404.00
  • CASK $7,522,832.00
  • Revenue This Year
  • ENSC $89.78
  • CASK N/A
  • Revenue Next Year
  • ENSC N/A
  • CASK N/A
  • P/E Ratio
  • ENSC N/A
  • CASK $43.53
  • Revenue Growth
  • ENSC 40.41
  • CASK N/A
  • 52 Week Low
  • ENSC $2.12
  • CASK $0.94
  • 52 Week High
  • ENSC $14.67
  • CASK $4.00
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 35.78
  • CASK N/A
  • Support Level
  • ENSC $5.34
  • CASK N/A
  • Resistance Level
  • ENSC $6.14
  • CASK N/A
  • Average True Range (ATR)
  • ENSC 0.43
  • CASK 0.00
  • MACD
  • ENSC -0.04
  • CASK 0.00
  • Stochastic Oscillator
  • ENSC 9.49
  • CASK 0.00

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About CASK HERITAGE DISTILLING HOLDING COMPANY INC

Heritage Distilling Holding Co Inc is a craft distiller producing, marketing and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon and by shipping directly to consumers online where legal. Currently, It sells products primarily in the Pacific Northwest with limited distribution in other states throughout the U.S.

Share on Social Networks: